IP Library Granted Patent US 11,073,512
Granted Patent B2
US 11,073,512 · App. 16/202,213 · Granted Jul 27, 2021

Multisignal reagents for labeling analytes

Inventors: Jack Coleman (East Northport, NY); Maciej Szczepanik (Mount Sinai, NY); Richard Jin (Pennington, NJ)
Assignee: Enzo Life Sciences, Inc.
G01N33/53C07H21/00C07H21/04C09B11/08C09B11/24C12Q1/6818G01N33/581G01N33/82G01N33/94
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,073,512
App. No.
16/202,213
Granted
Jul 27, 2021
Kind
B2
Abstract

Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The assay comprises: combining a sample suspected of containing the analyte with the above-described composition and a binding agent that binds to the analyte; and detecting the signal or the first member of the second binding pair that is bound to the binding agent. Additionally provided is a multisignal labeling reagent comprising a first polymer covalently bound to (a) a reactive group or a first member of a first binding pair, and (b) more than one digoxigenin molecule.

Claims (8)

1. A DNA oligonucleotide having a 5′ end and a 3′ end, comprising:

a first member of a first binding pair attached at the 5′ end of the DNA oligonucleotide, wherein the first binding pair is an antigen-antibody binding pair; and

a first member of a second binding pair attached at the 3′ end of the DNA oligonucleotide, wherein the second binding pair is an antigen-antibody binding pair.

2. The DNA oligonucleotide of claim 1 , wherein the first member of the first binding pair is a protein.

3. The DNA oligonucleotide of claim 2 , wherein the first member of the first binding pair is an antibody.

4. The DNA oligonucleotide of claim 1 , wherein the first member of the second binding pair is a protein.

5. The DNA oligonucleotide of claim 4 , wherein the first member of the second binding pair is an antibody.

6. The DNA oligonucleotide of claim 3 , wherein the first member of the second binding pair is an antibody.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: COLEMAN, JACK; JIN, RICHARD; SZCZEPANIK, MACIEJ
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 047727/0903 →
Continuity (6)
Continuation 15609360 · May 31, 2017
Division 13556425 · Jul 24, 2012
Continuation In Part 13065101 · Mar 14, 2011
Continuation In Part 12399393 · Mar 6, 2009
Division 10407818 · Apr 3, 2003
Related Publication 20190145964A1 · May 16, 2019